Clinical trial
The Novel Antihypertensive Goal Of hYpertension With diAbetes - Hypertensive Events and ARb Treatment (NAGOYA-HEART) Study
NCT00129233 is registered in ClinicalTrials.gov with Nagoya University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Novel Antihypertensive Goal Of hYpertension With diAbetes - Hypertensive Events and ARb Treatment (NAGOYA-HEART) Study
- Lead sponsor
- Nagoya University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2004
- Completion date
- April 30, 2013
- Enrollment
- 1,150 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypertension, type 2 diabetes mellitus